中/EN Contact/Message
Innovate
Bimervax
Bimervax
departments:预防科
drug:注射液
Active:SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer – B.1.351-B.1.1.7 strains
indication:Bimervax是一种预防16岁及以上人群2019年冠状病毒病(新冠肺炎)的疫苗。
Licensor:Hipra Human Health S.L.
Approved Country/Region:EMA
Approval time:2023-03-30